129 related articles for article (PubMed ID: 1131869)
21. [Effects of 2 successive injections of tolbutamide on blood sugar and blood insulin in normal humans].
Vague P; Rouvier-Leroy C; Vague J
Diabete; 1968; 16(2):143-5. PubMed ID: 5759100
[No Abstract] [Full Text] [Related]
22. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
[TBL] [Abstract][Full Text] [Related]
23. [Improvement in glucose tolerance and insulin sensitivity after a single administration of tolbutamide in hypertensive patients].
Dzúrik R; Dzúriková K; Spustová V
Vnitr Lek; 1991 Mar; 37(3):255-60. PubMed ID: 2031314
[TBL] [Abstract][Full Text] [Related]
24. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
Pelkonen R; Taskinen MR; Nikkilä EA
Int J Obes; 1977; 1(4):315-24. PubMed ID: 617112
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactive insulin level in the pancreatic vein after the intragastric administration of a single dose of tolbutamide in dogs.
Kawanishi K; Goto A; Ishida T
Acta Med Okayama; 1973 Dec; 27(5):185-93. PubMed ID: 4273585
[No Abstract] [Full Text] [Related]
26. Oral versus intravenous administration of butylbiguanide: effect on oral glucose tolerance in normal humans.
Berger EG; Moehr P
Eur J Clin Invest; 1976 Jun; 6(3):221-8. PubMed ID: 939245
[TBL] [Abstract][Full Text] [Related]
27. [Studies on the bio-availability of tolbutamide (author's transl)].
Rupp W; Dibbern HW; Hajdu P; Ross G; Vander Elst E
Dtsch Med Wochenschr; 1975 Mar; 100(13):690-5. PubMed ID: 1091434
[TBL] [Abstract][Full Text] [Related]
28. Effect of glucose infusion in dogs on blood sugar, insulinemia and serum free fatty acid responses.
Renauld A; Garrido D
Medicina (B Aires); 1992; 52(2):150-6. PubMed ID: 1308907
[TBL] [Abstract][Full Text] [Related]
29. Tolbutamide and glucagon secretion.
Loubatières AL; Loubatiéres-Mariani MM; Alric R; Ribes G
Diabetologia; 1974 Aug; 10(4):271-6. PubMed ID: 4607297
[No Abstract] [Full Text] [Related]
30. Characterisation of the effect of intravenous infusion of glucose and tolbutamide on the insulin delivery rate in man.
Asano T; Sasaki H; Okumura M
Diabetologia; 1978 Sep; 15(3):159-64. PubMed ID: 700280
[TBL] [Abstract][Full Text] [Related]
31. [Biguanides, glycemia and insulinemia (author's transl)].
Kulenda Z; Dub O
Cas Lek Cesk; 1974 Sep; 113(39):1201-3. PubMed ID: 4424987
[No Abstract] [Full Text] [Related]
32. [Prenatal treatment of hypotrophic foetuses by long-term glucose infusions. VII. Glucose tolerance tests performed in newborns prenatally treated for foetal hypotrophy (author's transl)].
Pribylová H; Sabata V
Cesk Gynekol; 1982 May; 47(4):256-60. PubMed ID: 7046960
[No Abstract] [Full Text] [Related]
33. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
34. [The effect of an infusion of glucose-insulin-potassium and of heparin on the plasma free fatty acid levels and on blood glucose].
Haslauer F; Krempler F; Bolzano K; Sandhofer F
Wien Klin Wochenschr; 1983 Sep; 95(17):618-21. PubMed ID: 6359725
[TBL] [Abstract][Full Text] [Related]
35. [Intravenous tolbutamide loading, serum insulin activity (ILA) and tolbutamide stimulated insulin reserve in patients with acne vulgaris].
Denk R; Knick B; Linde K
Z Haut Geschlechtskr; 1966 Dec; 41(11):429-34. PubMed ID: 4226565
[No Abstract] [Full Text] [Related]
36. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
37. Insulin and growth hormone secretion in the nephrotic syndrome.
Bridgman JF; Summerskill J; Buckler JM; Hellman B; Rosen SM
Q J Med; 1975 Jan; 44(173):115-23. PubMed ID: 1153688
[TBL] [Abstract][Full Text] [Related]
38. [Effect of intravenous administration of N 1-n-butylbiguanide on carbohydrate and lipid metabolism in diabetics].
Michaelis D; Lippmann HG; Köhler E
Dtsch Gesundheitsw; 1970 May; 25(19):870-4. PubMed ID: 5523783
[No Abstract] [Full Text] [Related]
39. Diurnal variation in the blood-sugar and plasma-insulin response to tolbutamide.
Baker IA; Jarrett RJ
Lancet; 1972 Nov; 2(7784):945-7. PubMed ID: 4116824
[No Abstract] [Full Text] [Related]
40. The behaviour of insulinaemia in patients ith liver cirrhosis after intravenous administration of glucose, tolbutamide and glucagon.
Kasperska T; Lawecki J; Rogala H; Czyzyk A
Diabetologia; 1971 Oct; 7(5):391-4. PubMed ID: 5134260
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
